Trevi Therapeutics Inc. (TRVI)
Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
Oil-Dri Corporation Of America (ODC)
Oil-Dri Announces Highest Third Quarter Results on Record
Biogen Inc (BIIB)
Biogen Announces Webcast of Annual Meeting of Stockholders
Avita Medical Ltd (RCEL)
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™
Amgen Inc (AMGN)
AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Adverum Biotechnologies Inc (ADVM)
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9 Meters Biopharma, Inc. (NMTRQ)
Early Reviews of the Switch 2 Highlight Significant Hardware Improvements
Corcept Therapeutics Incorporated (CORT)
Corcept stelt de resultaten voor van de Fase 2-studie van dazucorilant bij patiënten met ALS (amyotrofe laterale sclerose) tijdens de jaarlijkse bijeenkomst van de ENCALS 2025